The D-1 dopamine receptor: past, present and future an idiosyncratic review.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Progress in Neuro-psychopharmacology and Biological Psychiatry

• Publication date

  1995-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0278-5846(95)00129-JPMID 8539418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drugs for the Treatment of Parkinson’s Disease

  2011cited by this paper
• Selective D-1 dopamine receptor agonist treatment of parkinson's disease

  2005cited by this paper
• Chaos and physiology: deterministic chaos in excitable cell assemblies.

  1994cited by this paper
• Recent advances in the molecular biology of dopamine receptors.

  1993cited by this paper
• D1 dopamine agonist and antagonist effects on regional cerebral glucose utilization in rats with intact dopaminergic innervation.

  1993cited by this paper
• The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys.

  1993cited by this paper
• Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat.

  1993cited by this paper
• Relative potency and efficacy of some dopamine agonists with varying selectivities for D1 and D2 receptors in MPTP-induced hemiparkinsonian monkeys.

  1993cited by this paper
• L-dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors.

  1993cited by this paper
• The neostriatal mosaic: multiple levels of compartmental organization.

  1992cited by this paper
• A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets.

  1992cited by this paper
• The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia.

  1992cited by this paper
• D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease

  1992cited by this paper
• Expression of the Immediate Early Gene c-fos in Basal Ganglia: Induction by Dopaminergic Drugs

  1991cited by this paper
• Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.

  1991cited by this paper
• Fractal and chaotic dynamics in nervous systems.

  1991cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper
• D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.

  1989cited by this paper
• Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.

  1988cited by this paper
• When time breaks down

  1987cited by this paper
• D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients.

  1986cited by this paper
• Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.

  1986cited by this paper
• [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor.

  1986cited by this paper
• The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390.

  1984cited by this paper
• Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

  1984cited by this paper
• SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

  1983cited by this paper
• Phase locking, period-doubling bifurcations, and irregular dynamics in periodically stimulated cardiac cells.

  1981cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis

  1978cited by this paper
• Studies on renal dopamine receptors with a new agonist.

  1978cited by this paper
• The central effects of a novel dopamine agonist.

  1978cited by this paper
• Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro.

  1977cited by this paper
• Simple mathematical models with very complicated dynamics

  1976cited by this paper
• Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.

  1974cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

  1972cited by this paper
• Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour.

  1971cited by this paper
• Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission

  1971cited by this paper
• Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

  1971cited by this paper
• The Cerebellum as a Neuronal Machine

  1967cited by this paper

• Methamphetamine Self-Administration: Neurochemical Consequences and Behavioural Effects

  2012cites this paper
• DAD1‐ and DAD2‐like agonist effects on motor activity of C57 mice: Differences compared to rats

  1997cites this paper